Fifth consecutive time in RESPECT Index for Pelion
For the fifth consecutive time Pelion S.A., Poland’s largest healthcare company, secured a place in the RESPECT Index, again confirming its adherence to the highest standards of responsible and sustainable business.
The official announcement of the Index review results and presentation of membership certificates took place at the offices of the Warsaw Stock Exchange on December 14th 2016. The new RESPECT Index portfolio covers a record number of 25 companies and will be valid as of December 19th 2016.
They have passed a multi-stage qualification process, involving a thorough assessment of the extent and comprehensiveness of their stakeholder-focused activities. Among the evaluated areas were business management strategies and techniques, HR and environmental policies, as well as market- and customer-oriented initiatives.
Pelion’s inclusion in the RESPECT Index for the fifth time proves that the company runs its business in a responsible and sustainable manner, and that it meets the expectations of its stakeholders, creating partnerships based on trust and transparency.
Another inclusion in the RESPECT Index also confirms the soundness of the company’s core values, which have been the foundation of its everyday activity for 25 years. In accordance with its mission of ‘Long and quality life’, Pelion focuses fully on patients and their needs, providing them with innovative and comprehensive healthcare solutions. Pelion also aims to serve patients with support throughout the process of pharmacotherapy, as well as with expert knowledge, modern solutions in disease prevention and treatment and access to a wide range of affordable medicines.
RESPECT Index is the first index of socially responsible companies (SRI) in Central and Eastern Europe. It includes the most liquid companies, which are market leaders in corporate governance, quality reporting and investor relations, and which stand out for their environmental, social and employee-related performance.The Index represents a valid point of reference for stock market investors, who want to be sure that they invest in highly-liquid companies run to the best-in-class standards of management.
For further information, please contact:
Pelion S.A. Press Office
Phone: (+48 42) 200 75 94
Fax: (+48 42) 200 75 35
Email: biuro_prasowe@pelion.eu
Pelion S.A. has operated on the market for twenty-six years, starting out as a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Today, Pelion Healthcare Group is one of the largest groups operating in the healthcare markets in Poland and Lithuania. It provides services across all market segments (wholesale, retail sales and sales to hospitals), targeted at individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Company’s operations, which are conducted by PGF S.A. and Pharmapoint S.A. (wholesale), CEPD N.V. (retail) and PGF Urtica Sp. z o.o. and Pharmalink Sp. z o.o. (hospital supplies and logistics services).
